Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new indication for its monoclonal antibody Uplizna. Thursday, the FDA greenlighted ...

Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. The MINT trial ...

Uplizna targets CD19-positive B cells, offering a novel treatment approach for generalized myasthenia gravis by addressing a biological root cause of the disease. The Phase III MINT trial demonstrated ...

The op-ed highlights persistent gaps in gMG diagnosis, treatment, and access. It outlines the socio-economic burden and the need to optimise care pathways in this disorder and the broader rare ...

The FDA expanded the indication of inebilizumab (Uplizna) to include generalized myasthenia gravis (gMG), Amgen announced Friday. The drug is now approved to treat gMG in adults who are ...

Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...

In 2004, a man from Graz, Austria, began a gruelling two-decade journey with generalized myasthenia gravis (gMG), a rare autoimmune disease that causes muscle weakness and fatigue. Over the years, he ...

PART 1 A Brief History of Emotional Intelligence Everyone values EI, but actually learning the component skills is another matter entirely. By Marc Brackett, Ph.D., and Robin Stern, Ph.D. Thirty-four ...

Hello, dear readers! Welcome to our monthly letters column. We’ve had some interesting mail, so we’ll get right to it.

Intense pain during a bowel movement sent our son to the ER. He got diagnosed with a blood clot in a hemorrhoid and needed surgery to fix it.